Novartis signs a global deal with Formulatrix.
"We have been very pleased with the implementation of the Rock Maker platform at Novartis. Rock Maker has allowed us to improve our productivity using our existing crystallization robotic hardware. A key benefit has been integrating the entire crystallization process from experimental design through data management under Formulatrix' comprehensive, user-friendly software platform. We have also been happy with the continued support of Rock Maker and the commitment to meet our specific needs."
Travis Stams Novartis Institutes for Biomedical Research